PPM1B KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 3.
MGC21657, OTTHUMP00000158953, OTTHUMP00000158954, OTTHUMP00000158955, OTTHUMP00000202394, OTTHUMP00000202395, OTTHUMP00000202399, PP2C beta X, PP2C-beta, PP2CB, PPC2BETAX, PPM1B_HUMAN, Protein phosphatase 1B, Protein phosphatase 1B magnesium dependent beta isoform, Protein phosphatase 2C beta isoform, Protein phosphatase 2C isoform beta, Protein phosphatase 2C like protein, Protein phosphatase, Mg2+/Mn2+ dependent, 1B, protein phosphatase 1B (formerly 2C) magnesium-dependent beta isoform
PPM1B KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 3.
Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.
1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
PPM1B also known as protein phosphatase 1B is a serine/threonine phosphatase with a molecular mass of approximately 55 kDa. This protein plays an important role in dephosphorylating serine/threonine residues on its target proteins adjusting their functional states. PPM1B is widely expressed in various tissues throughout the body including the heart skeletal muscle and liver. Its activity helps in modulating different signaling pathways by reversing the phosphorylation status of target proteins.
PPM1B influences diverse cellular processes such as cell cycle regulation and stress response. It is not part of a large complex but interacts with specific substrates to exert its effects. PPM1B can impact apoptosis and cell differentiation through its action on certain substrates. Its regulatory function is important for maintaining cellular homeostasis and adaptation to environmental changes.
Multiple signaling cascades demonstrate the involvement of PPM1B. It plays a significant role in the regulation of the p38 MAPK pathway which is important for stress response and inflammatory processes. In this pathway PPM1B interacts with MAPKAPK2 modulating its activity. PPM1B also participates in the TGF-beta signaling pathway where it can affect the phosphorylation status of SMADs. These interactions emphasize PPM1B's regulatory importance in response to extracellular signals.
Alterations in PPM1B activity are linked to cardiovascular and inflammatory conditions. For example changes in its function can contribute to the pathogenesis of hypertension through its effect on the TGF-beta pathway and related proteins like SMAD2. In inflammatory diseases the role of PPM1B in the p38 MAPK pathway shows its connection to proteins such as MAPKAP2 highlighting its potential involvement in inflammatory responses. These connections demonstrate the therapeutic interest in targeting PPM1B for disease treatment and management.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Homozygous: 2 bp deletion in exon 3
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com